Your browser doesn't support javascript.
loading
Bedside Electrophysiological Study Using a Temporary Pacemaker May Predict Recurrence of Atrioventricular Block After Transcatheter Aortic Valve Replacement.
Nauchi, Masahiro; Yamawaki, Masahiro; Nakano, Takahide; Makino, Kenji; Honda, Yosuke; Sakai, Tsuyoshi; Ito, Yoshiaki.
Afiliação
  • Nauchi M; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
  • Yamawaki M; Department of Cardiology, Heisei Yokohama Hospital.
  • Nakano T; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
  • Makino K; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
  • Honda Y; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
  • Sakai T; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
  • Ito Y; Cardiovascular Center, Saiseikai Yokohamashi Tobu Hospital.
Int Heart J ; 62(5): 1012-1018, 2021 Sep 30.
Article em En | MEDLINE | ID: mdl-34544981
ABSTRACT
High-degree atrioventricular block (HAVB) or complete heart block (CHB) is a common complication associated with transcatheter aortic valve replacement (TAVR). However, some patients with HAVB/CHB recover with time. The results of electrophysiological studies (EPSs) using permanent pacemaker implantation (PPI) in patients with suspicious HAVB/CHB are considered controversial.This study aimed to evaluate whether HAVB/CHB induction at the bedside using a temporary pacemaker can predict recurrence in patients who had recovered from HAVB/CHB after TAVR.We enrolled a total of 11 patients who had recovered from HAVB/CHB and evaluated their electrophysiology using right ventricular pacing and/or procainamide administration.HAVB/CHB induction was positive. Three patients tested positive for HAVB/CHB, whereas 8 tested negative. The ejection fraction and the interval between HAVB/CHB onset and EPS were found to be significant. HAVB/CHB positive patients underwent PPI. A patient with a balloon-expandable valve tested positive just before recovery of CHB, but tested negative 5 days later and was included in the negative group. The 4 patients who tested negative received a cardiovascular implantable electric device (CIED). We observed HAVB/CHB in 2 patients who had previously tested positive after 3 months. Among those who tested negative, those with CIED had no HAVB/CHB, and others showed neither HAVB/CHB on electrocardiogram nor experienced syncope or sudden death.Our EPS revealed that HAVB/CHB induction may predict HAVB/CHB recurrence after TAVR. Valve type and EPS timing may affect the results.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Bloqueio Atrioventricular / Eletrofisiologia Cardíaca / Substituição da Valva Aórtica Transcateter Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int Heart J Assunto da revista: CARDIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Bloqueio Atrioventricular / Eletrofisiologia Cardíaca / Substituição da Valva Aórtica Transcateter Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int Heart J Assunto da revista: CARDIOLOGIA Ano de publicação: 2021 Tipo de documento: Article